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Abstract
Background: The prevalence of allergic diseases has increased over recent decades in affluent countries, but
remains low in rural populations and some non-affluent countries. An explanation for these trends is that increased
exposure to infections may provide protection against the development of allergy. In this work we investigated the
association between exposure to viral infections in children living in urban Brazil and the prevalence of atopy and
asthma.
Methods: School age children living in poor neighborhoods in the city of Salvador were studied. Data on asthma
symptoms and relevant risk factors were obtained by questionnaire. Skin prick tests (SPTs) were performed to
seven aeroallergens, and specific IgE was measured to four of these. Viral infections were determined by the
presence of specific IgG in serum to Herpes simplex (HSV), Herpes zoster (HZV), Epstein-Barr (EBV), and Hepatitis A
(HAV) viruses.
Results: A total of 644 (49.7%) children had at least one allergen-specific IgE> 0.35 kU/L and 489 (37.7%) had
specific IgE> 0.70 kU/L. A total of 391 (30.2%) children were skin test positive (SPT+), and 295 (22.8%) children were
asthmatic. The seroprevalence of viral infections was 88.9% for EBV, 55.4% for HSV, 45.5% for VZV and 17.5% for
HAV. Negative associations were observed between SPT+ and HSV (OR = 0.64, CI = 0.51, 0.82) and EBV (OR = 0.63,
CI = 0.44, 0.89) infections, but no associations were seen between viral infections and the presence of allergen-
specific IgE or asthma.
Conclusion: These data do not support previous data showing a protective effect of HAV against atopy, but did
show inverse associations between SPT+ (but not specific IgE+) and infections with HSV and EBV. These findings
suggest that different viral infections may protect against SPT+ in different settings and may indicate an
immunoregulatory role of such infections on immediate hypersensitivity responses. The data provide no support
for a protective effect of viral infections against asthma in this population.
Background
The prevalence of allergic diseases, such as rhinitis,
asthma and eczema has increased in affluent countries
over recent decades, and may have increased also in
cities of non-affluent countries such as in Latin America
[1]. Such temporal trends occurring over a relatively
short period of time are unlikely to be explained by
changes in genetic susceptibility and are most likely
explained by changes in environmental exposures such
as those associated with the adoption of a modern or
‘westernized’ lifestyle [2].
Strachan [3] observed that children lower in the birth
order had a reduced prevalence of hay fever and inter-
preted this observation in terms of younger children being
more highly exposed to infections in early life through con-
tact with their older siblings. This interpretation, coined
the hygiene hypothesis, and has been widely promoted to
explain the temporal trends in allergic disease prevalence.
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Allergic diseases are complex inflammatory disorders
with significant genetic components [4,5] and are
strongly influenced by environmental factors [6-8].
Allergic inflammation is considered to develop following
immediate hypersensitivity reactions to environmental
antigens which leads to the development of an immune
response characterized by high levels of IgE and
increased numbers of eosinophils and mast cell cells,
and a Th2 immune profile [9]. In the early 1990 s, with
the discoveries of Th1 and Th2 lymphocyte populations
in animal models and the realization that infection with
bacteria and viruses induce the innate immune system
to release Th1 cytokines, a possible biological explana-
tion for the hygiene hypothesis emerged. When born, a
child has a predominantly Th2 immune response,
requiring the presence of infections to stimulate the
Th1 system in early childhood and achieve a balance
between Th1 and Th2 responses to prevent a Th2 bias
that favor Th2 allergic diseases [10]. Although humans
may respond differently to infections, there is epidemio-
logical evidence for inverse associations between infec-
tions and allergic diseases that support this hypothesis.
Such infections include hepatitis A [11], Herpes simplex
[12] and Epstein-Barr viruses [13], viral lower respira-
tory tract infections [14], and Mycobacterium tuberculo-
sis infection [15].
To test the hypothesis that childhood viral infections
protect against allergy and asthma, we compared the
seroprevalence of common childhood viral infections
between children with and without atopy and asthma
living in poor neighborhoods in a Brazilian city.
Methods
Population and study design
The study was conducted in a cohort of 1,445 children
living in poor neighborhoods of Salvador, a city with a
population of 2.5 million with a high prevalence of
asthma [16]. This cohort of children aged 4-13 years
was derived from an earlier study on the impact of sani-
tation on childhood diarrhea conducted in 24 sentinel
areas in Salvador, and the study design is described in
detail elsewhere [17]. A questionnaire to collect infor-
mation on risk factors, demographic factors, and key
allergic symptoms [ISAAC-based] was administered to
the child’s parent or guardian in 2005. The children
underwent skin prick tests (SPTs) to seven aeroaller-
gens. Blood samples were collected and the sera were
stored at -20°C and used to measure IgG to relevant
pathogens and allergen-specific IgE (sIgE).
This study was approved by the Ethics Committee for
Research of the Instituto de Saúde Coletiva da Universi-
dade Federal da Bahia and CONEP (National Council of
Ethics in Research); written consent to participate in the
work, containing information about history of allergies
and their risk factors, was obtained from parents or
guardians.
Asthma definition
Children were classified as having asthma if parents
reported wheezing in the previous 12 months and at
least one of the following: (i) diagnosis of asthma ever;
(ii) wheezing with exercise in the last 12 months; (iii) 4
episodes wheezing in the last 12 months; (iv) waking up
at night because of wheezing in the last 12 months.
Skin prick test
The SPT was carried out using ALK-Abello reagents
(São Paulo, Brazil) for the following allergens identified
as regionally relevant by previous unpublished work:
Dermatophagoides pteronyssinus, Blomia tropicalis, Blat-
tella germanica, Periplaneta americana, dog and cat
epithelia, and a mixture of fungi (Aspergillus amstelo-
dami, A. fumigatus, A. niger, A. terrus, Penicillium brevi-
compactum, P. expansum, P. notatum, P. roqueforti,
Cladosporium fulvum, and C. herbarum). Positive and
negative controls were 10 mg/mL histamine and saline,
respectively. Allergens and controls were applied to the
right forearm. After 15 minutes, the reaction was mea-
sured and was considered positive when the mean wheal
diameter was at least 3 mm greater than the negative
control. Children positive for at least one of the studied
allergens were classified as SPT positive. Children who
used anti-allergic drugs were excluded from the study.
Measurements of anti-aeroallergen IgE antibodies
The presence of specific IgE antibodies to D. pteronyssi-
nus, B. tropicalis, P. americana and B. germanica in the
children’s sera was determined using the lmmunoCap
system (Phadia Uppsala, Sweden). These antigens were
chosen because they were the most frequently observed
to cause SPT reactivity in these children. The results,
expressed in kU/L (lower limit corresponding to 2.4 ng/
ml), were obtained by a standard curve produced by
serial dilutions of human IgE against a standard serum
IgE provided by the World Health Organization (WHO
standard 75/502). The IgE cut preconized by the manu-
facturer is 0.35 kU/L. However cross-reactivities
between allergen reactive IgEs and many organisms,
including helminthes have being reported at this cut-off
[18]. That is why we decided to use both IgE ≥0.35 kU/
L and ≥0.70 kU/L cut-offs. Children were considered
positive when they had values greater than these cut-off
points for at least one of the studied allergens.
Detection of viral IgG
The presence of serum antibodies in the children’s sera
against herpes simplex (HSV), herpes zoster (HZV) and
Epstein-Barr (EBV) viruses was determined by ELISA
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assay using kits from Diamedix (Miami, Florida, USA),
following the manufacturer’s instructions. For the hepa-
titis A virus (HAV), kits from ADALTIS were used
(Toronto, Canada). The cut-off points were determined
by the index derived from the relationship: absorbance
of sample/calibrator absorbance (solution containing
human serum or defibrinated plasma weakly reactive for
antibodies against the respective virus and 0.1% sodium
azide). Indices greater than 1.1 were considered positive,
less than 0.9 were considered negative and between 1.1
and 0.9 were considered indeterminate, and these chil-
dren were excluded from the analysis.
Statistical analysis
Analyses were done with children with no missing data for
the variables analyzed, and comparisons were made
between the studied and the excluded groups using the
chi-square test or the t-test (two-tailed). We assessed the
association between the presence of serum antibodies for
the 4 viruses (main exposures) and specific serum IgE, skin
reactivity for environmental allergens and the presence of
asthma (outcome variables). Potential confounders for the
association between virus infections and outcomes were:
maternal education, presence of a sewage disposal system,
frequency of changing bed linen, number of siblings, pre-
sence of cat and dog in the house, smoking parents, pre-
sence of mold or dampness in the walls of the house (by
inspection) and if the child had attended daycare.
Although we collected data about children vaccination,
none was vaccinated for the viruses used in this analysis,
and then, this variable was removed from the study.
The associations between exposure outcomes (IgE, SPT
and asthma) were assessed using logistic regression to
estimate odds ratios (OR) and 95% confidence intervals
(CIs). Variables were entered individually in multivariate
models and if the variable was non-significant (P > 0.05)
it was removed, but if significant, was kept in the analysis.
Only significant variables were kept in the models. Gen-
der and age were considered a priori confounders and
kept in all models. Analysis on multiplicative interactions
between each infection and gender in relation to all out-
comes was done, and co-linearity between viral infections
was also assessed. Finally, we tested for the effects of
clustering by neighborhood, using random effects mod-
els, but because such adjustment did not alter effects,
results without adjustment for clustering were provided.
Analyses were performed using SPSS (Release 16.0, SPSS,
Inc) and multinomial (polytomous) logistic regression
analyses using STATA (Release 9.0, Stata Corp).
Results
Characteristics of study population
Of the 1,445 children enrolled in the cohort, 89.7%
(1296) with complete data were included in the present
analysis. No significant differences were found between
the 149 excluded and the 1,296 studied included within
respect to relevant baseline variables. The mean age of
the children was 7.2 years (standard deviation (SD =
1.7), and 53.8% were male. A history of parental asthma
was present in 13.3% of the children, and 27.4% had at
least one smoker at home. The results showed that
44.2% of the children had the bed linen changed more
than once a week, 82.8% had a sewage system in their
home, 64.9% had mold and moisture in the walls of
their houses, and 39.6% lived with dogs and 17.7% with
cats. Only 386 (29.8%) of the children had mothers who
had completed secondary education. Children had, on
average, 1.8 (SD = 1.8) siblings. Only 209 (16%) children
had attended daycare. Seropositivity for the studied
viruses was 88.9% for EBV, 55.4% for HSV, 45.5% for
VZV and 17.5% for HAV. Seroprevalence increased with
age, and only herpes simplex was found to be associated
with gender (greater in girls; data not shown). The pre-
valence of IgE-sensitization using the two cut-offs were:
IgE> 0.35 kU/L, and IgE> 0.70 kU/L, 49.7% and 37.7%,
respectively. SPT positivity for at least one of the stu-
died allergens was present in 30.2% of the children, and
the prevalence of asthma was 22.8% (Table 1).
All studied viral infections were associated with each
other (data not shown); however, comparing the logistic
models using all infections in the same model or with
each infection in separate models, there was no signifi-
cant change in the ORs for the 3 infection-outcome
associations, so we included all infections in the same
model. There was not important heterogeneity of effect
for any of the variables studied using multiplicative
interaction terms between each infection and gender in
relation to the outcomes (Data not shown).
Associations of viral infections with anti-IgE antibodies to
environmental allergens
Among potential risk factors, only gender was signifi-
cantly associated with specific IgE using a cut-off of IgE
≥ 0.70 (boys > girls, Table 1). No association was found
between viral infections and the presence of specific IgE
to environmental allergens using either cut-off (≥0.35
and ≥0.70) (Table 1 and 2).
Associations of viral infections with skin prick test (SPT)
for environmental allergens
Only gender was significantly associated with SPT, being
more frequent in boys. A negative association of SPT
with both HSV and EBV infections were observed (unad-
justed, OR = 0.64; CI = 0.51-0.82 and OR = 0.63; CI =
0.44-0.89, respectively; adjusted for age and sex, OR =
0.66; CI = 0.51-0.84 and adjusted OR = 0.69; CI = 0.48-
0.99, respectively). No associations were found between
SPT and HAV and VZV infections (Table 1 and 3).
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Association of viral infections with asthma
No infection was significantly associated with asthma in
either univariate or multivariate analyses. Moisture and
mold on the walls and daycare attendance were signifi-
cantly associated with asthma in univariate but not in
multivariate analysis (Tables 1 and 4). No association
was found between the viral infections and either atopic
or non-atopic asthma using atopic non-asthmatic or
non-atopic non-asthmatic children as comparison
groups, respectively (Table 5).
Discussion
In our study, we found no association between the HSV
infection and the presence of aerollaergen-specific IgE or
asthma; however, a significant negative association was
observed with SPT in multivariate analyses, indicating that
exposures to this infection may be associated with
suppression of immediate hypersensitivity responses. The
immune response of allergic diseases is typically Th2; thus,
it is possible that pathogenic or non-pathogenic organisms
(or their molecules) that suppress this response can induce
protection from allergies. Among the known factors that
can suppress a Th2 immune response, one can highlight
Th1 and T-regulatory (T-reg) cells stimulators. In vitro
studies have shown that HSV DNA can induce tumor
necrosis factor (TNFa) and interleukin (IL)-6, a Th1
immune response, and release interferon (IFN)-g [19].
Matricardi and collaborators [20], studying a North Amer-
ican population, showed that HSV protected against
asthma and hay fever. Janson and colleagues [12], studying
young adults in Iceland, Sweden and Estonia, showed that
HSV was negatively associated with atopy.
Our data showed that EBV was negatively associated
with skin reactivity. EBV has a different mechanism of
Table 1 Associations between viral infections with aeroallergen IgE, skin test reactivity (SPT) and asthma
Variables
N = 1296
Total population n = 1296 Number and percentage of children positive for the outcomes
IgE ≥ 0.70
n = 489 (37.7%)
SPT
n = 391 (30.2%)
Asthma
n = 295 (22.8%)
n (%) n (%) p-value n (%) p-value n (%) p-value
Gender
Male 697(53.8) *306(43.9) <0.001 233(33.4) 0.006 164(23.5) 0.477
Age (years)
4-6 333(25.7) 123(36.9) 0.914 92(27.6) 0.230 113(33.9) <0.001
6 and 7 531(41.0) 200(37.7) 156(29.4) 117(22.0)
7-11 432(33.3) 166(38.4) 143(33.1) 65(15.0)
Parental asthma 173(13.3) 57(32.9) 0.163 50(28.9) 0.696 61(35.3) <0.001
Sibling no.
0 241(18.6) 98(40.7) 0.683 78(32.4) 0.213 54(22.4) 0.936
1 459(35.4) 167(36.4) 148(32.2) 109(23.7)
2 306(23.6) 118(38.6) 91(29.7) 67(21.9)
3 or more 290(22.4) 106(36.6) 74(25.5) 65(22.4)
Mother’s education
Illiterate 177(13.7) 74(41.8) 0.616 50(28.2) 0.570 54(30.5) 0.025
Primary complete 444(34.3) 160(36.0) 126(28.4) 102(23.0)
Secondary incomplete 289(22.3) 109(37.7) 90(31.1) 66(22.8)
Secondary complete 386(29.8) 146(37.8) 125(32.4) 73(18.9)
Daycare ever Yes 208(16.0) 77(37.0) 0.817 53(25.5) 0.108 61(29.3) 0.014
Smoker at home 355(27.4) 127(35.8) 0.372 99(27.9) 0.272 88(24.8) 0.285
Sewage system Yes 1073(82.8) 414(38.6) 0.165 327(30.5) 0.599 242(22.6) 0.694
Change bed linen1 × week 573(44.2) 212(37.0) 0.628 173(30.2) 0.988 137(23.9) 0.381
Cat at home Yes 230(17.7) 83(36.1) 0.570 61(26.5) 0.184 66(28.7) 0.018
Dog at home Yes 513(39.6) 187(36.5) 0.442 147(28.7) 0.336 129(25.1) 0.098
Mold/moisture at home 841(64.9) 318(37.8) 0.935 253(30.1) 0.926 210(25.0) 0.010
Seropositivity
Herpes simplex 712(54.9) 254(35.7) 0.092 185(26.0) <0.001 158(22.2) 0.588
Varicella zoster 588(45.4) 216(36.7) 0.500 171(29.1) 0.437 132(22.4) 0.806
Epstein-Barr 1149(88.7) 423(36.8) 0.057 333(29.0) 0.009 258(22.5) 0.460
Hepatitis A 224(17.3) 80(37.7) 0.493 65(29.0) 0.680 50(22.3) 0.863
*Numbers shown in bold are statistically significant (Chi2 test; p < 0.05).
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protection of allergic diseases. It induces T-regs cells as
an escape mechanism from the immune system, and
although this mechanism has not been well elucidated, it
seems to involve an elevation of IL-10 and transforming
growth factor (TGF)-b. Wingate and collaborators [21]
and Marshall and collaborators [22] found in the EBV
genome a well-preserved sequence homologous to IL-10,
which may be influencing this immunomodulation [23].
Several studies have reported EBV associated with pro-
tection of atopy [13,24].
In relation to HAV infection, our data, as well as
others in the literature [12,25,26] showed no evidence of
its association with the study outcomes. In addition to
being an indicator of poor hygiene conditions, the HAV
can also have an immunoregulatory role in reducing
asthma in its hosts. Polymorphism of a receptor (TIM-
Table 2 Logistic regression analyses of association between seropositivity to common viral infections of childhood
and the presence of aeroallergen-specific IgEs using cut-offs for specific IgE of ≥0.35 and ≥0.70 kU/L
Infection by
N = 1296
*sIgE ≥0.35 (n = 644/49.7%) sIgE ≥ 0.70 (n = 489/37.7%)
OR (95% C.I.) OR (95% C.I.)
n (%)/N Crude Adjusted** n (%)/N Crude Adjusted**
HSV
Negative 298(51.0)/584 1 1 235(40.2)/584 1 1
Positive 346(48.6)/712 0.91
(0.73; 1.13)
0.94
(0.75; 1.18)
254(35.7)/712 0.82
(0.66; 1.03)
0.88
(0.69; 1.11)
VZV
Negative 357(50.4)/708 1 1 273(38.6)/708 1 1
Positive 287(48.8)/588 0.94
(0.75; 1.17)
0.93
(0.74; 1.17)
216(36.7)/588 0.93
(0.74; 1.16)
0.93
(0.74; 1.17)
EBV
Negative 80(54.4)/147 1 1 66(44.9)/147 1 1
Positive 564(49.1)/1149 0.81
(0.57; 1.14)
0.82
(0.58; 1.17)
423(36.8)/1149 0.71
(0.51; 1.01)
0.75
(0.53; 1.07)
HAV
Negative 531(49.5)/1072 1 1 409(38.2)/1072 1 1
Positive 113(50.4)/224 1.04
(0.78; 1.38)
1.07
(0.80; 1.44)
80(35.7)/224 0.90
(0.67; 1.22)
0.94
(0.69; 1.28)
*Aeroallergen-specific IgE; **Adjusted for gender and age.
Table 3 Logistic regression analyses of associations
between viral infections and skin prick test reactivity
(SPT) for at least one aeroallergen
Infection by
N = 1296
SPT ≥0.3 mm
n = 391 (30.2%)
n (%)/N OR (95% C.I.)
Crude Adjusted*
HSV
Negative 206 (35.3)/584 **1 1
Positive 185 (26.0)/712 0.64 (0.51; 0.82) 0.66 (0.51; 0.84)
VZV
Negative 220 (31.1)/708 1 1
Positive 171 (29.1)/588 0.91 (0.72; 1.15) 0.89 (0.70; 1.14)
EBV
Negative 58 (39.5)/147 1 1
Positive 333 (29.0)/1149 0.63 (0.44; 0.89) 0.69 (0.48; 0.99)
HAV
Negative 326 (30.4)/1072 1 1
Positive 65 (29.0)/224 0.94 (0.68; 1.28) 1.01 (0.73; 1.40)
*Adjusted for gender and age. **Bold values are statistically significant (p <
0.05).
Table 4 Logistic regression analyses of associations
between viral infections and asthma
Infection by Asthma
n = 295 (22.8%)
N = 1272 n (%)/N OR (95% C.I.)
Crude Adjusted*
HSV
Negative 137 (23.5)/584 1 1
Positive 158 (22.2)/712 0.93 (0.72; 1.21) 1.02 (0.77; 1.35)
VZV
Negative 163 (23.0)/708 1 1
Positive 132 (22.4)/588 0.97 (0.75; 1.26) 1.09 (0.82; 1.43)
EBV
Negative 37 (25.2)/147 1 1
Positive 258 (22.5)/1149 0.86 (0.58; 1.28) 0.81 (0.53; 1.23)
HAV
Negative 245 (22.9)/1072 1 1
Positive 50 (22.3)/224 0.97 (0.69; 1.37) 0.99 (0.69; 1.42)
*Asthma defined as at least 1 case of 4 or more episodes of wheeze within
the last 12 months, waking up in the night with shortness of breath, wheeze
post-exercise or asthma diagnosed by doctor **Adjusted for gender, age,
parental asthma, mother’s education and cat at home.
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1) used by the hepatitis A virus to invade cells may be
related to allergy [27,28]. Some studies have shown that
HAV infection is negatively associated with allergic dis-
eases [11,20,29,30]. This difference in findings in differ-
ent geographic regions indicates that environmental and
genetic factors may be influencing the ability of this
virus to immunomodulate atopy and allergy or not.
In our study, there was no evidence that VZV infec-
tion was associated with the modulation of allergic
responses or disease. However, Zhang and colleagues
[31] and Janson and colleagues [12] showed that lym-
phocyte cultures stimulated with this virus could
enhance the production of Th1 cytokines. Nilsson and
colleagues [13] have also not find any association of this
infection with atopy and allergic symptoms in children.
Although in this study EBV and HSV were inversely
associated with SPTs, there was no association of these
viral infections with specific IgEs against common aller-
gens either using 0.35 or 0.70 kU/L as cut-offs. One pos-
sible explanation for these findings is that the presence of
EBV, which had high prevalence (88.9%) in our popula-
tion, stimulated the production of IL-10, thereby prevent-
ing mast cell degranulation, even in the presence of IgE
and thus decreasing SPT reactivity in children with ele-
vated sIgEs. Another possible explanation is that our
population, in contrast to affluent countries, is constantly
infected and re-infected by helminths, which have been
associated with elevated levels of IgE levels to aeroaller-
gens due to possible cross-reactivity between parasite
antigens and aeroallergens [18]. Possibly, as significant
component of the specific IgE detected by Immunocap
assays are in fact cross-reactive antibodies, which may
not have enough affinity for the aeroallergen molecules
and therefore do not crosslink in the FCεRII, a necessary
step for the occurrence of mast cell degranulation.
The clinical diagnosis of asthma is difficult in pre-
school children. Most of the epidemiological studies use
symptoms of asthma (wheezing in the last 12 months)
or doctor’s diagnosis of asthma as the indicators. In the
current study we screened all children with a history of
wheezing in the last 12 months with a few other ques-
tions aiming to increase the specificity of our criteria for
asthma: diagnosis of asthma ever, wheezing with exer-
cise; ≥ 4 episodes wheezing, waking up night because of
wheezing. They had to have at least one extra positive
answer to the queries. Although we suppose our criteria
are more accurate than the usual epidemiological defini-
tions, we acknowledge the possibility some of the chil-
dren we classified as having asthma may have transient
wheezing. For that reason we made an analysis exclud-
ing children younger than 6 years, the only finding that
differ from the previous analysis was the association of
EBV infection with specifc IgE which was borderline in
the whole children population analysis and became sta-
tistically significant but without differ the odds ratio in
the analysis with children above 6 year old.
Many studies in the literature have shown negative
associations between viral infections and asthma [12-14];
however, there was no strong evidence that the viral
infections studied in our population mediate the develop-
ment of asthma. Pearce and collaborators [32] showed
that the positive association between SPTs and asthma is
lower in developing countries than in developed coun-
tries. Given the large amount of non-atopic asthma
found in the children studied herein [33], this may be a
possible explanation for the absence an association
between asthma and any of the studied viral infections.
Furthermore, our data indicate the absence of association
of the viral infection with asthma is not restricted to
non-atopic asthma, but also to atopic asthma.
Table 5 Polytomous logistic regression analyses of associations between viral infections and asthma
N = 1296 Non-atopic asthmatic
N = 154
Atopic asthmatic
N = 141
n (%) OR (C.I)* n (%) OR (C.I)* OR (C.I)**
HSV
No (n = 584) 70(20.1) 1 67(19.4) 1 1
Yes (n = 712) 84(18.3) 0.96(0.66; 1.40) 74(16.5) 0.94(0.64; 1.38) 1,15(0,76; 1,73)
VZV
No (n = 708) 86(19.8) 1 77(18.1) 1 1
Yes (n = 588) 68(18.3) 1.06(0.74; 1.54) 64(17.4) 1.04(0.71; 1.52) 1,15(0,77; 1,74)
EBV
No (n = 147) 17(21.0) 1 20(23.8) 1 1
Yes (n = 1149) 137(18.9) 0.82(0.46; 1.48) 121(17.0) 0.64(0.37; 1.13) 0,87(0,48; 1,57)
HAV
No (n = 1072) 124(18.7) 1 121(18.3) 1 1
Yes (n = 224) 30(20.8) 1.20(0.75; 1.92) 20(14.9) 0.83(0.49; 1.41) 0,79(0,45; 1,39)
*Odds ratio for comparison with non-atopic non-asthmatics. Adjusted for gender, age, parental asthma, mother’s education and cat at home.
** Odds ratio for comparison with atopic non-asthmatics. Adjusted for gender, age, parental asthma, mother’s education and cat at home.
Veiga et al. BMC Pulmonary Medicine 2011, 11:24
http://www.biomedcentral.com/1471-2466/11/24
Page 6 of 8
Conclusion
Our data provide further evidence that common viral
infections of childhood are associated with an attenua-
tion of immediate hypersensitivity responses in children
but not clinical disease. Given that most asthma is not
associated with atopy in our study population, the data
indicate that factors other than infection should be
investigated as causing asthma in populations living in
non-affluent countries.
Study Limitation
The current work is based solely on serology and does
not take into account the age of infection or chronicity
of infection. Another limitation is its inability to estab-
lish causality, since it is a cross-sectional analysis in
which there is no information on the temporal sequence
between exposure and outcome.
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